Treatment of central serous chorioretinopathy with topical NSAIDs
Sepehr Bahadorani,1 Kyle Maclean,1 Kendall Wannamaker,1 Edward Rickie Chu,1 Nathan Gresores,2 Jeong-Hyeon Sohn,1 Roberto Diaz-Rohena,1 Michael A Singer21Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; 2Medical Center Ophthalmology Associat...
Enregistré dans:
Auteurs principaux: | Bahadorani S, Maclean K, Wannamaker K, Chu ER, Gresores N, Sohn JH, Diaz-Rohena R, Singer MA |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3d09e27f5f2a41e68a9509b25d8f3f63 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
par: Mohabati D, et autres
Publié: (2020) -
Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy
par: Ambiya V, et autres
Publié: (2016) -
Central Serous Chorioretinopathy: Pathogenesis and Management
par: Semeraro F, et autres
Publié: (2019) -
Deep Learning for Detecting Subretinal Fluid and Discerning Macular Status by Fundus Images in Central Serous Chorioretinopathy
par: Fabao Xu, et autres
Publié: (2021) -
Photodynamic therapy in combination with intravitreal ziv-aflibercept and aflibercept injection in patients with chronic or repeatedly recurrent acute central serous chorioretinopathy: a single-center retrospective study
par: Doepfner JM, et autres
Publié: (2018)